Jack Griffin is a Vice President focused on primary investments in third-party CLO funds, as well as the structuring and origination of Carlyle-sponsored CLO funds. Prior to joining Carlyle in 2018, he was at MUFG Securities where he specialized in the structuring and origination of CLOs. He started his career at Ernst & Young LLP in their Structured Finance Valuations Group.
Jack received his B.A. in economics from Connecticut College and maintains Series 7, 63, and 79 licenses. He is based in New York.
Let's spread the word about Immunotherapy! Click to share this page with your community.